TWI512291B - Method for detecting compound by thin-layer chromatograph mass spectrometry - Google Patents
Method for detecting compound by thin-layer chromatograph mass spectrometry Download PDFInfo
- Publication number
- TWI512291B TWI512291B TW102116006A TW102116006A TWI512291B TW I512291 B TWI512291 B TW I512291B TW 102116006 A TW102116006 A TW 102116006A TW 102116006 A TW102116006 A TW 102116006A TW I512291 B TWI512291 B TW I512291B
- Authority
- TW
- Taiwan
- Prior art keywords
- compound
- mass spectrometry
- thin layer
- layer chromatography
- acid
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims description 59
- 238000004949 mass spectrometry Methods 0.000 title claims description 40
- 238000000034 method Methods 0.000 title claims description 33
- 238000004809 thin layer chromatography Methods 0.000 claims description 57
- 238000004458 analytical method Methods 0.000 claims description 30
- 239000000758 substrate Substances 0.000 claims description 25
- 239000002105 nanoparticle Substances 0.000 claims description 24
- 238000006243 chemical reaction Methods 0.000 claims description 20
- 239000002082 metal nanoparticle Substances 0.000 claims description 20
- 239000000047 product Substances 0.000 claims description 17
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 claims description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- 150000007524 organic acids Chemical class 0.000 claims description 12
- 239000011159 matrix material Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 9
- 238000000926 separation method Methods 0.000 claims description 9
- BRARRAHGNDUELT-UHFFFAOYSA-N 3-hydroxypicolinic acid Chemical compound OC(=O)C1=NC=CC=C1O BRARRAHGNDUELT-UHFFFAOYSA-N 0.000 claims description 8
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 claims description 7
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- AFVLVVWMAFSXCK-UHFFFAOYSA-N α-cyano-4-hydroxycinnamic acid Chemical compound OC(=O)C(C#N)=CC1=CC=C(O)C=C1 AFVLVVWMAFSXCK-UHFFFAOYSA-N 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 5
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 claims description 5
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 claims description 5
- 239000013067 intermediate product Substances 0.000 claims description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- 102000053602 DNA Human genes 0.000 claims description 4
- 108020004414 DNA Proteins 0.000 claims description 4
- 239000003054 catalyst Substances 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 239000010931 gold Substances 0.000 claims description 4
- 229920002477 rna polymer Polymers 0.000 claims description 4
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 claims description 3
- -1 3,5- dimethoxy-4-hydroxyphenyl acrylate Chemical compound 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 3
- 235000012000 cholesterol Nutrition 0.000 claims description 3
- 229910017052 cobalt Inorganic materials 0.000 claims description 3
- 239000010941 cobalt Substances 0.000 claims description 3
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 3
- 239000002207 metabolite Substances 0.000 claims description 3
- 229930014626 natural product Natural products 0.000 claims description 3
- 229910052759 nickel Inorganic materials 0.000 claims description 3
- 239000000376 reactant Substances 0.000 claims description 3
- 229930186217 Glycolipid Natural products 0.000 claims description 2
- 150000001336 alkenes Chemical class 0.000 claims description 2
- 150000001345 alkine derivatives Chemical class 0.000 claims description 2
- 150000001408 amides Chemical class 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims description 2
- 150000001540 azides Chemical class 0.000 claims description 2
- 230000003115 biocidal effect Effects 0.000 claims description 2
- 235000020958 biotin Nutrition 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 150000004696 coordination complex Chemical class 0.000 claims description 2
- 150000002016 disaccharides Chemical class 0.000 claims description 2
- 235000001785 ferulic acid Nutrition 0.000 claims description 2
- 229940114124 ferulic acid Drugs 0.000 claims description 2
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052737 gold Inorganic materials 0.000 claims description 2
- 150000002391 heterocyclic compounds Chemical class 0.000 claims description 2
- 150000002632 lipids Chemical class 0.000 claims description 2
- 238000001906 matrix-assisted laser desorption--ionisation mass spectrometry Methods 0.000 claims description 2
- 230000004060 metabolic process Effects 0.000 claims description 2
- 238000012544 monitoring process Methods 0.000 claims description 2
- 239000002858 neurotransmitter agent Substances 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 150000004756 silanes Chemical class 0.000 claims description 2
- 229910052709 silver Inorganic materials 0.000 claims description 2
- 239000004332 silver Substances 0.000 claims description 2
- 150000003568 thioethers Chemical class 0.000 claims description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 claims 6
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 2
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 claims 2
- 108010015899 Glycopeptides Proteins 0.000 claims 2
- 102000002068 Glycopeptides Human genes 0.000 claims 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 2
- 229940081066 picolinic acid Drugs 0.000 claims 2
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapic acid Chemical compound COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 claims 2
- VZXTWGWHSMCWGA-UHFFFAOYSA-N 1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(N)=N1 VZXTWGWHSMCWGA-UHFFFAOYSA-N 0.000 claims 1
- DWQOTEPNRWVUDA-CCEZHUSRSA-N 2-(4-hydroxyphenylazo)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1\N=N\C1=CC=C(O)C=C1 DWQOTEPNRWVUDA-CCEZHUSRSA-N 0.000 claims 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 claims 1
- 239000005711 Benzoic acid Substances 0.000 claims 1
- 229960004365 benzoic acid Drugs 0.000 claims 1
- 235000010233 benzoic acid Nutrition 0.000 claims 1
- 239000011616 biotin Substances 0.000 claims 1
- 229960002685 biotin Drugs 0.000 claims 1
- 150000002772 monosaccharides Chemical class 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- 239000000243 solution Substances 0.000 description 30
- 239000000203 mixture Substances 0.000 description 17
- 238000001819 mass spectrum Methods 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 239000000543 intermediate Substances 0.000 description 8
- 239000007858 starting material Substances 0.000 description 8
- 239000012491 analyte Substances 0.000 description 7
- 239000008367 deionised water Substances 0.000 description 7
- 229910021641 deionized water Inorganic materials 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 239000002904 solvent Substances 0.000 description 5
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- SHXWCVYOXRDMCX-UHFFFAOYSA-N 3,4-methylenedioxymethamphetamine Chemical compound CNC(C)CC1=CC=C2OCOC2=C1 SHXWCVYOXRDMCX-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 229930182776 Ugonin Natural products 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- BKBSGDFMEPRLDG-UHFFFAOYSA-N 2-[2-(2-hydroxyethoxy)ethoxy]-1-methoxyethanol Chemical compound COC(O)COCCOCCO BKBSGDFMEPRLDG-UHFFFAOYSA-N 0.000 description 2
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 2
- 230000010933 acylation Effects 0.000 description 2
- 238000005917 acylation reaction Methods 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 238000000703 high-speed centrifugation Methods 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- OQGSCHGFHOSXFY-UHFFFAOYSA-N 1,2-dichloroethenylbenzene Chemical compound ClC=C(Cl)C1=CC=CC=C1 OQGSCHGFHOSXFY-UHFFFAOYSA-N 0.000 description 1
- FZTLLUYFWAOGGB-UHFFFAOYSA-N 1,4-dioxane dioxane Chemical compound C1COCCO1.C1COCCO1 FZTLLUYFWAOGGB-UHFFFAOYSA-N 0.000 description 1
- ISYLVKCGXLBQOU-UHFFFAOYSA-N 2-[(2-hydroxyphenyl)diazenyl]benzoic acid Chemical compound OC(=O)c1ccccc1N=Nc1ccccc1O ISYLVKCGXLBQOU-UHFFFAOYSA-N 0.000 description 1
- FGEAOSXMQZWHIQ-UHFFFAOYSA-N 2-chloro-2-phenylacetyl chloride Chemical compound ClC(=O)C(Cl)C1=CC=CC=C1 FGEAOSXMQZWHIQ-UHFFFAOYSA-N 0.000 description 1
- VMZCDNSFRSVYKQ-UHFFFAOYSA-N 2-phenylacetyl chloride Chemical compound ClC(=O)CC1=CC=CC=C1 VMZCDNSFRSVYKQ-UHFFFAOYSA-N 0.000 description 1
- LXCFLOSCXGXJGS-UHFFFAOYSA-N 3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoic acid Chemical compound COC=1C=C(C=CC(=O)O)C=C(C1O)OC.COC=1C=C(C=CC(=O)O)C=C(C1O)OC LXCFLOSCXGXJGS-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 241000135026 Helminthostachys zeylanica Species 0.000 description 1
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000004057 biotinyl group Chemical class [H]N1C(=O)N([H])[C@]2([H])[C@@]([H])(SC([H])([H])[C@]12[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229960002069 diamorphine Drugs 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hcl hcl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- AKMJJGSUTRBWGW-UHFFFAOYSA-N pyridine-2-carboxylic acid Chemical compound OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1 AKMJJGSUTRBWGW-UHFFFAOYSA-N 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Description
本發明係有關於一種分析方法,且特別係有關於一種結合薄層層析法(thin layer chromatography,TLC)與質譜法(Mass spectrometry,MS)的分析方法。 The present invention relates to an analytical method, and in particular to an analytical method combining thin layer chromatography (TLC) and mass spectrometry (MS).
於化學反應過程中,通常使用薄層層析法(TLC)監控(monitor)化學反應,以判斷化學反應完成與否。一般可藉由將待測物與標準樣品(reference)作比對,以判斷待測物質的化學結構。然而,在無適當標準品,或欲監控化學反應步驟或是中間產物較為複雜時,不容易僅由薄層層析法判斷待測物的結構。因此,需要其他的分析方法,以幫助判斷待測物的化學結構。 During the chemical reaction, the chemical reaction is usually monitored using thin layer chromatography (TLC) to determine whether the chemical reaction is complete or not. Generally, the chemical structure of the substance to be tested can be judged by comparing the analyte to a standard sample. However, in the absence of an appropriate standard, or when the chemical reaction step or the intermediate product is to be monitored, it is not easy to judge the structure of the analyte by thin layer chromatography alone. Therefore, other analytical methods are needed to help determine the chemical structure of the analyte.
質譜分析法(MS)藉由分析待測物的分子量以判斷待測物的化學結構。結合薄層層析法與質譜分析法可達到分離與得知待測物的結構資料。然而,由於繁瑣的樣品製備與有機酸基質在小分子量(小於500Da)的區域造成干擾,使得分析技術上受限。 Mass spectrometry (MS) determines the chemical structure of the analyte by analyzing the molecular weight of the analyte. Combined with thin layer chromatography and mass spectrometry, the structural data of the analyte can be separated and obtained. However, analytical techniques are limited due to cumbersome sample preparation and interference with organic acid matrices in areas of small molecular weight (less than 500 Da).
因此,業界極須發展一種利用薄層層析質譜分析 化合物的方法,此方法簡單且快速,且不需要外加基質,能有效分析低分子量的待測物。 Therefore, the industry must develop a thin layer chromatography mass spectrometry The method of the compound is simple and rapid, and does not require an external matrix, and can effectively analyze the low molecular weight analyte.
本發明提供一種利用薄層層析質譜分析化合物的方法,包括以下步驟:(a)提供一樣品,其中該樣品溶於一分離溶液中且該樣品中具有複數個化合物;(b)將該樣品點附於一基板(plate)上,藉由一薄層層析法(thin layer chromatography)分離該樣品,以得到複數個分析點,其中每一個分析點包括至少一個化合物;(c)將一奈米粒子溶液滴於該些分析點,使該些化合物吸附於該奈米粒子溶液中;(d)對該基板進行一乾燥步驟;以及(e)將吸附上該些化合物的該基板直接置入一質譜儀中,以進行質譜分析。 The present invention provides a method for analyzing a compound by thin layer chromatography mass spectrometry, comprising the steps of: (a) providing a sample, wherein the sample is dissolved in a separation solution and the sample has a plurality of compounds; (b) the sample is The dots are attached to a plate, and the sample is separated by a thin layer chromatography to obtain a plurality of analysis points, wherein each analysis point includes at least one compound; (c) a rice particle solution is dropped on the analysis points to adsorb the compounds in the nanoparticle solution; (d) a drying step is performed on the substrate; and (e) the substrate on which the compounds are adsorbed is directly placed In a mass spectrometer, mass spectrometry is performed.
為讓本發明之上述和其他目的、特徵、和優點能更明顯易懂,下文特舉出較佳實施例,並配合所附圖式,作詳細說明如下: The above and other objects, features and advantages of the present invention will become more <RTIgt;
12‧‧‧基板 12‧‧‧Substrate
14‧‧‧滴管 14‧‧‧ Dropper
16‧‧‧奈米粒子溶液 16‧‧‧Nano particle solution
16a‧‧‧金屬奈米粒子 16a‧‧‧Metal Nanoparticles
16b‧‧‧有機酸 16b‧‧‧Organic acid
S1、S2、S3‧‧‧分析點 S1, S2, S3‧‧‧ analysis points
第1A~1D圖為一系列剖面圖,用以說明本發明之利用薄層層析質譜分析化合物的方法之流程圖。 1A to 1D are a series of cross-sectional views for explaining a flow chart of the method for analyzing a compound by thin layer chromatography mass spectrometry of the present invention.
第2A-2H圖分別顯示本發明實施例2的質譜圖。 Fig. 2A-2H shows the mass spectrum of Example 2 of the present invention, respectively.
第3圖顯示實施例3之質譜圖。 Figure 3 shows the mass spectrum of Example 3.
第4A~4F圖分別顯示比較例1、比較例2與實施例4之質譜圖。 Figures 4A to 4F show mass spectra of Comparative Example 1, Comparative Example 2, and Example 4, respectively.
第5A圖顯示本發明實施例5之中間產物(intermediate III) 之質譜圖。 Figure 5A shows an intermediate product (intermediate III) of the fifth embodiment of the present invention. Mass spectrum.
第5B圖顯示本發明實施例5之產物(product IV)之質譜圖。 Figure 5B shows a mass spectrum of the product (product IV) of Example 5 of the present invention.
第6A~6B圖顯示本發明實施例偵測天然物之質譜圖。 Figures 6A-6B show mass spectra of natural matter detected by an embodiment of the present invention.
本發明提供一種利用薄層層析質譜分析化合物的方法,包括以下步驟(a)-步驟(e)。第1A~1D圖為一系列剖面圖,用以說明本發明之利用薄層層析質譜分析化合物的方法之流程圖。首先,進行步驟(a),提供樣品,其中樣品溶於分離溶液中且樣品中具有複數個化合物。此處所謂「樣品」即為待測的樣品,待測樣品中通常具有許多不同的化合物,可藉由後續的分析方法將其分離。 The present invention provides a method for analyzing a compound by thin layer chromatography mass spectrometry comprising the following steps (a) to (e). 1A to 1D are a series of cross-sectional views for explaining a flow chart of the method for analyzing a compound by thin layer chromatography mass spectrometry of the present invention. First, step (a) is carried out to provide a sample in which the sample is dissolved in the separation solution and the sample has a plurality of compounds. The "sample" here is the sample to be tested. The sample to be tested usually has many different compounds, which can be separated by subsequent analysis methods.
此外,步驟(a)之樣品可來自於化學反應過程中的反應物(reactant)、中間產物(intermediate)或產物(product),以及時(real time)監控化學反應。 Further, the sample of step (a) may be derived from a reactant, an intermediate or a product during a chemical reaction, and the chemical reaction is monitored at a real time.
分離溶液包括二氯甲烷(dichloromethane,DCM)、甲醇(methanol)、乙酸乙酯(ethyl acetate,EA)、正己烷(n-hexane)、丙酮(acetone)、氯仿(chloroform)、甲苯(toluene)或水。然而,分離溶液並不限於上述提及之溶劑,本領域人士可依據實際應用之需求,選擇所需的分離溶液。 The separation solution includes dichloromethane (DCM), methanol, ethyl acetate (EA), n-hexane, acetone, chloroform, toluene or water. However, the separation solution is not limited to the above-mentioned solvents, and those skilled in the art can select the desired separation solution depending on the needs of the actual application.
之後,進行步驟(b),將樣品點附於基板(plate)上,藉由薄層層析法(thin layer chromatography)分離該樣品,以得到複數個分析點,其中每一個分析點包括至少一個化合物。請參見第1A圖,其顯示經過薄層層析法(thin layer chromatography)後,基板12之上具有複數個分析點S1,S2,S3。 Thereafter, step (b) is performed, the sample point is attached to a plate, and the sample is separated by thin layer chromatography to obtain a plurality of analysis points, wherein each analysis point includes at least one Compound. See Figure 1A, which shows thin layer chromatography (thin layer) After chromatography, the substrate 12 has a plurality of analysis points S1, S2, S3.
基板12包括鋁片(alumina)、矽膠片(silica gel)或玻璃基板。於一較佳實施例中,可直接使用市售TLC板(例如矽膠片)作為本發明之基板,並不需要特別修飾此基板。 The substrate 12 includes an aluminum plate, a silica gel or a glass substrate. In a preferred embodiment, a commercially available TLC plate (e.g., tantalum film) can be used directly as the substrate of the present invention, and the substrate need not be specially modified.
薄層層析法(TLC)是一種層析法(chromatography),主要利用矽膠(silica gel)或鋁片(alumina)作為層析靜相(stationary phase),再將樣品點附在此薄層靜相上,以液體展開劑作為流動相(mobile phase),透過毛細作用由下往上移動,以分離出各種不同成分。此外,薄層層析法(TLC)還可以用於追蹤化學反應的進行程度。 Thin layer chromatography (TLC) is a chromatography method, mainly using silica gel or aluminum as a stationary phase, and attaching sample points to the thin layer. In contrast, a liquid developer is used as a mobile phase to move from bottom to top by capillary action to separate various components. In addition, thin layer chromatography (TLC) can also be used to track the extent of chemical reactions.
於步驟(b)中,由於樣品本身可能是透明無色,而分析點S1、S2、S3也可能是透明無色,因此,本發明之利用薄層層析質譜分析化合物的方法尚包括利用紫外光(UV)或是染劑(staining buffer)觀察該些分析點S1、S2、S3。 In the step (b), since the sample itself may be transparent and colorless, and the analysis points S1, S2, and S3 may also be transparent and colorless, the method for analyzing the compound by thin layer chromatography mass spectrometry of the present invention includes using ultraviolet light ( UV) or staining buffer to observe the analysis points S1, S2, S3.
接著,進行步驟(c),請參見第1B圖,利用滴管14將奈米粒子溶液16滴於該些分析點S1、S2、S3,使該些化合物吸附於奈米粒子溶液16中。請參見第1C圖,奈米粒子溶液16中包括複數個金屬奈米粒子16a與修飾於該些金屬奈米粒子16a上的有機酸16b。 Next, in step (c), referring to FIG. 1B, the nanoparticle solution 16 is dropped on the analysis points S1, S2, and S3 by the pipette 14, and the compounds are adsorbed to the nanoparticle solution 16. Referring to FIG. 1C, the nanoparticle solution 16 includes a plurality of metal nanoparticles 16a and an organic acid 16b modified on the metal nanoparticles 16a.
該些金屬奈米粒子16a包括鐵(Fe)、鈷(Co)、鎳(Ni)、金(Au)、銀(Ag)或上述之組合。該些有機酸16b包括2,5-二羥基苯甲酸(2,5-dihydroxybenzoic acid,DHB)、3,5-二甲氧基-4-羟基苯丙烯酸(3,5-dimethoxy-4-hydroxycinnamic acid,SA)、α-氰基-4-羟基肉桂酸(α-Cyano-4-hydroxycinnamic acid, α-CHC)、3-(4-羥基-3-甲氧苯基)-2-丙烯酸)[(E)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoic acid,Ferulic acid]、吡啶甲酸(pyridine-2-carboxylic acid,Picolinic acid)、3-羟基-2-吡啶甲酸(3-hydroxypyridine-2-carboxylic acid,3-HPA)、2-(對羥基苯偶氮)苯甲酸[2-(4'-Hydroxybenzeneazo)benzoic acid,HABA]。 The metal nanoparticles 16a include iron (Fe), cobalt (Co), nickel (Ni), gold (Au), silver (Ag), or a combination thereof. The organic acids 16b include 2,5-dihydroxybenzoic acid (DHB) and 3,5-dimethoxy-4-hydroxycinnamic acid (3,5-dimethoxy-4-hydroxycinnamic acid). , SA), α- cyano-4-hydroxycinnamic acid (α-cyano-4-hydroxycinnamic acid, α -CHC), 3- (4- hydroxy-3-methoxyphenyl) -2-propenoic acid) [( E)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enoic acid, Ferulic acid], pyridine-2-carboxylic acid (Picolinic acid), 3-hydroxy-2-picolinic acid ( 3-hydroxypyridine-2-carboxylic acid, 3-HPA), 2-(4'-Hydroxybenzeneazo)benzoic acid (HABA).
於一較佳實施例中,金屬奈米粒子16a具有磁性,例如鐵(Fe)、鈷(Co)、鎳(Ni)。使用磁性金屬奈米粒子之優點在於,後續可回收再利用磁性金屬奈米粒子,以節省製程成本。 In a preferred embodiment, the metal nanoparticles 16a have magnetic properties such as iron (Fe), cobalt (Co), and nickel (Ni). The advantage of using magnetic metal nanoparticles is that the magnetic metal nanoparticles can be recycled and reused to save process costs.
於一實施例中,可先將2,5-二羥基苯甲酸(2,5-dihydroxybenzoic acid,DHB)修飾到氧化鐵(Fe3O4)奈米粒子上,之後,添加適當的溶劑,以形成奈米粒子溶液16。 In one embodiment, 2,5-dihydroxybenzoic acid (DHB) may be first modified onto iron oxide (Fe 3 O 4 ) nanoparticles, and then a suitable solvent is added to A nanoparticle solution 16 is formed.
須注意的是,當奈米粒子溶液16滴於該些分析點S1、S2、S3時,因為金屬奈米粒子16a上修飾上有機酸16b,使金屬奈米粒子16a表面具有特定官能基,例如芳香環(aromatic rings)、羧酸鹽(carboxylate)、羥鹽(hydroxyl group),這些官能基與欲分析的化合物之間可產生電荷-電荷作用力(charge-charge interaction)、氫鍵(hydrogen bonding)與疏水效應(hydrophobic effect),因此,使化合物被吸附於奈米粒子溶液16中的金屬奈米粒子16a上,因而達到萃取濃縮步驟,進行提高偵測靈敏度。另外,溶劑的選擇會影響萃取(extraction)濃縮的效果,可依據實際應用之需求,選擇極性與所欲分析的化合物極性接近的溶劑,以提高濃縮的效果。 It should be noted that when the nanoparticle solution 16 is dropped on the analysis points S1, S2, and S3, since the organic acid 16b is modified on the metal nanoparticle 16a, the surface of the metal nanoparticle 16a has a specific functional group, for example, Aromatic rings, carboxylates, hydroxyl groups, which can generate charge-charge interaction and hydrogen bonding between the functional groups and the compound to be analyzed. And the hydrophobic effect, therefore, the compound is adsorbed on the metal nanoparticle 16a in the nanoparticle solution 16, thereby achieving the extraction concentration step, and improving the detection sensitivity. In addition, the choice of solvent affects the effect of extraction concentration, and the solvent having a polarity close to that of the compound to be analyzed can be selected according to the needs of the actual application to enhance the concentration effect.
之後,進行步驟(d),對基板12進行一乾燥步驟。 乾燥步驟例如使用氮氣吹乾(purge)基板12。 Thereafter, step (d) is performed to perform a drying step on the substrate 12. The drying step purges the substrate 12, for example, using nitrogen gas.
接著,進行步驟(e),請參見第1C圖,將吸附上該些化合物的基板12直接置入質譜儀中,以進行質譜分析。質譜儀包括基質輔助雷射脫附離子化質譜儀(matrix-assisted laser desorption ionization,MALDI)。第1D圖顯示質譜圖,X軸代表化合物的質量電荷比(m/z),Y軸代表訊號強度(intensity)。 Next, step (e) is performed. Referring to FIG. 1C, the substrate 12 on which the compounds are adsorbed is directly placed in a mass spectrometer for mass spectrometry. The mass spectrometer includes a matrix-assisted laser desorption ionization (MALDI). Figure 1D shows the mass spectrum, with the X-axis representing the mass-to-charge ratio (m/z) of the compound and the Y-axis representing the signal intensity.
須注意的是,進行步驟(e)之前,由於金屬奈米粒子16a上修飾的有機酸16b可扮演基質的作用,亦即,能幫助能量轉移,因此,不需要額外添加基質(matrix)到基板上。另言之,本發明可”直接”將基板置於質譜儀中,不需要經過複雜的樣品萃取過程,可節省製程成本與時間。 It should be noted that before the step (e), since the modified organic acid 16b on the metal nanoparticle 16a can function as a matrix, that is, it can help energy transfer, therefore, no additional matrix is required to the substrate. on. In addition, the present invention allows the substrate to be placed "directly" in the mass spectrometer without the need for a complicated sample extraction process, which saves process cost and time.
於習知技術中,進行基質輔助雷射脫附離子化質譜儀(matrix-assisted laser desorption ionization,MALDI)時,偵測低分子量時(分子量小於500Da)通常會受到基質(matrix)的干擾,而影響分析結果。相較於習知技術,本發明所使用的有機酸修飾於奈米粒子溶液中的金屬奈米粒子上,因此,有機酸雖然可扮演基質的角色(可幫助質子轉移),但是卻不會產生基質的干擾,因此,可使本發明之方法有效應用於偵測低分子量之化合物,且可達到較佳的偵測靈敏度。 In the prior art, when performing matrix-assisted laser desorption ionization (MALDI), when detecting low molecular weight (molecular weight less than 500 Da), it is usually interfered by matrix. Affect the analysis results. Compared with the prior art, the organic acid used in the present invention is modified on the metal nanoparticles in the nanoparticle solution. Therefore, although the organic acid can play the role of a matrix (which can help proton transfer), it does not occur. The interference of the matrix allows the method of the present invention to be effectively applied to detect low molecular weight compounds and achieve better detection sensitivity.
本發明所偵測的該些化合物之分子量為約100-2000Da,較佳為約100-500Da。本發明之分析方法其偵測靈敏度可達到fmole(10-15mole)等級。 The compounds detected by the present invention have a molecular weight of from about 100 to about 2000 Da, preferably from about 100 to about 500 Da. The detection method of the present invention can achieve a detection sensitivity of fmole (10 -15 mole).
本發明所揭露之利用薄層層析質譜分析化合物的方法,其中化合物包括有機分子、生物分子或無機物分子。有 機分子包括酸類分子(acid)、酯類分子(ester)、醛類分子(aldehyde)、烷類分子(alkane)、烯類分子(alkene)、炔類分子(alkyne)、胺類分子(amine)、醯胺類分子(amide)、芳香烴化合物(aromatic hydrocarbons)、疊氮化合物(azide)、雜環化合物(heterocyclic compound)、硫化物(sulfide)、矽氧化合物(silane)、天然物(natural product)或有機催化劑中間體(intermediate)。 The method for analyzing a compound by thin layer chromatography mass spectrometry disclosed in the present invention, wherein the compound comprises an organic molecule, a biomolecule or an inorganic molecule. Have The molecular molecules include acid, ester, aldehyde, alkane, alkene, alkyne, and amine. , amide, aromatic hydrocarbons, azide, heterocyclic compounds, sulfides, silanes, natural products Or an organic catalyst intermediate (intermediate).
此外,有機分子亦包括各種毒品,例如鴉片(opium)、安非他命(amphetamine)、嗎啡(morphine)、海洛因(heroin)、大麻(marijuana)、古柯鹼(cocaine)、搖頭丸(3,4-methylenedioxy-methamphetamine,MDMA)、K他命(ketamine)等。 In addition, organic molecules include various drugs such as opium, amphetamine, morphine, heroin, marijuana, cocaine, and ecstasy (3,4-methylenedioxy- Methamphetamine, MDMA), ketamine, etc.
生物分子包括蛋白質(protein)、胜肽(peptide)、去氧核醣核酸(deoxyribonucleic acid,DNA)/核醣核酸(ribonucleic acid,RNA)與其代謝物(metabolism)、脂質(lipid)、膽固醇(cholesterol)與其代謝物、單醣分子(saccharide)、雙醣分子(disaccharide)、醣脂質(glycolipid)、醣胜肽(glycopeptide)、維他命(vitamine)、生物素(biotin)、神經傳導分子(neurotransmitter)、抗生素(antibiotic)。 Biomolecules include proteins, peptides, deoxyribonucleic acid (DNA)/ribonucleic acid (RNA) and its metabolism, lipid, cholesterol and its Metabolites, saccharides, disaccharides, glycolipids, glycosides, vitamins, biotins, neurotransmitters, antibiotics Antibiotic).
無機物分子包括金屬錯合物(metal complex)或金屬催化劑中間體(catalyst intermediate)。 The inorganic molecules include a metal complex or a catalyst intermediate.
須注意的是,習知技術中,由於代謝物中通常含有鹽類(如鈉、鉀),這些鹽類通常會干擾質譜分析結果。相較於習知技術,本發明之實施例較佳可應用於偵測小分子量的代 謝物,因為本發明進行薄層層析法(thin layer chromatography,TLC),鹽類不會溶解於分離溶液中,因此,可去除鹽類的干擾。 It should be noted that in the prior art, since the metabolite usually contains salts (such as sodium and potassium), these salts usually interfere with the results of mass spectrometry. Compared with the prior art, embodiments of the present invention are preferably applicable to detecting small molecular weight generations. Since the present invention performs thin layer chromatography (TLC), the salt does not dissolve in the separation solution, and therefore, the interference of the salt can be removed.
於一實施例中,本發明之利用薄層層析質譜分析化合物的方法可應用於監控親核取代反應(nucleophilic substitution reaction)的過程,當起始物甲氧基三乙二醇(methoxyl triethylene glycol,C7H16O4,分子量164.1)與2-氯-2-苯基乙烯氯(2-chloro-2-phenylacetyl chloride)反應後,會得到酯類產物(C15H21ClO5,分子量316.1)。可由基質輔助雷射脫附離子化質譜儀(matrix-assisted laser desorption ionization,MALDI)偵測到起始物與產物。 In one embodiment, the method of the present invention for analyzing a compound by thin layer chromatography mass spectrometry can be applied to the process of monitoring a nucleophilic substitution reaction, when the starting material is methoxyl triethylene glycol. , C 7 H 16 O 4 , molecular weight 164.1), after reacting with 2-chloro-2-phenylacetyl chloride, an ester product (C 15 H 21 ClO 5 , molecular weight 316.1) is obtained. ). The starting materials and products can be detected by matrix-assisted laser desorption ionization (MALDI).
於另一實施例中,本發明之利用薄層層析質譜分析化合物的方法可應用於監控4-二甲氨基吡啶(4-dimethylaminopyridine,DMAP)所催化的醯化反應(acylation),可藉由本發明所揭露之方法偵測到中間產物(intermediate),以及時(real time)監控化學反應,並判斷反應完成與否。 In another embodiment, the method for analyzing a compound by thin layer chromatography mass spectrometry of the present invention can be applied to monitor acylation catalyzed by 4-dimethylaminopyridine (DMAP), which can be used by The method disclosed by the invention detects an intermediate, monitors the chemical reaction in real time, and judges whether the reaction is completed or not.
綜上所述,本發明提供一種利用薄層層析質譜分析化合物的方法,其結合薄層層析法(thin layer chromatography)與質譜法,利用薄層層析法進行分離,結合質譜偵測化合物的分子量,並藉由將奈米粒子溶液滴於基板上,以萃取濃縮化合物,於不需要額外添加基質的條件下,直接將基板進行質譜分析,此方法可應用於分析各種有機分子、生物分子或無機物分子,特別是針對低分子量(100-500Da)的小分子。此外,本發明所提供之利用薄層層析質譜分析化合物的方 法可應用於及時(real time)監控化學反應,於化學反應過程中,可偵測反應物(reactant)、中間產物(intermediate)或產物(product),以判斷反應進行完全與否。 In summary, the present invention provides a method for analyzing a compound by thin layer chromatography mass spectrometry, which combines thin layer chromatography with mass spectrometry, separates by thin layer chromatography, and detects a compound by mass spectrometry. Molecular weight, and by dropping the nanoparticle solution onto the substrate to extract the concentrated compound, the substrate is directly subjected to mass spectrometry without additional matrix addition, and the method can be applied to the analysis of various organic molecules and biomolecules. Or inorganic molecules, especially for small molecules of low molecular weight (100-500 Da). In addition, the present invention provides a method for analyzing a compound by thin layer chromatography mass spectrometry. The method can be applied to monitor chemical reactions in real time. During the chemical reaction, reactants, intermediates or products can be detected to determine whether the reaction is complete or not.
(1)將FeCl2‧4H2O與FeCl3依序加入鹽酸(HCl)水溶液中(經過去氧處理),攪拌混合並反應2小時,以得到混合物A。 (1) FeCl 2 ‧4H 2 O and FeCl 3 were sequentially added to an aqueous solution of hydrochloric acid (HCl) (deoxidized), and the mixture was stirred and reacted for 2 hours to obtain a mixture A.
(2)將步驟(1)之混合物A緩慢加入氫氧化鈉(NaOH)水溶液中(經過去氧處理),得到混合物B。 (2) The mixture A of the step (1) is slowly added to an aqueous solution of sodium hydroxide (NaOH) (deoxidized) to obtain a mixture B.
(3)將混合物B分裝到離心管(centrifuge tube),並加入二次去離子水(dd-water)到離心管中,震盪均勻後,去除水溶液層。 (3) The mixture B is dispensed into a centrifuge tube, and secondary deionized water (dd-water) is added to the centrifuge tube, and after shaking uniformly, the aqueous layer is removed.
(4)將0.01N鹽酸水溶液(HCl)緩慢滴入離心管並攪拌2分鐘,去除上清液(supermatnat)後,最後再加入二次去離子水回溶,得到氧化鐵奈米粒子溶液(Fe3O4@MNP)。 (4) Slowly drip 0.01N aqueous hydrochloric acid solution (HCl) into the centrifuge tube and stir for 2 minutes, remove the supernatant (supermatnat), and finally add secondary deionized water to dissolve back to obtain iron oxide nanoparticle solution (Fe). 3 O 4 @MNP).
(5)取氧化鐵奈米粒子溶液置於單頸瓶中,再加入丙醇,以高速震盪30分鐘,以得到混合物C。 (5) The iron oxide nanoparticle solution was placed in a single-necked flask, and then propanol was added thereto, and shaken at high speed for 30 minutes to obtain a mixture C.
(6)將四乙氧基矽烷(Tetraethylorthosilicate,TEOS)與28-30%的氨水(NH4OH)加入混合物C中,於60℃下反應2小時,以得到混合物D。 (6) Tetraethylorthosilicate (TEOS) and 28-30% aqueous ammonia (NH 4 OH) were added to the mixture C, and reacted at 60 ° C for 2 hours to obtain a mixture D.
(7)將混合物D依序以丙醇和二次去離子水進行清洗,並用高速離心去除上清液,重複此步驟3次,以得到混合物E。 (7) The mixture D was washed sequentially with propanol and secondary deionized water, and the supernatant was removed by high speed centrifugation, and this step was repeated 3 times to obtain a mixture E.
(8)製備有機酸:將2,5-二羥基苯甲酸 (2,5-dihydroxybenzoic acid,DHB)溶於3ml二次去離子水中,並加入0.01NHCl,以得到混合物F。 (8) Preparation of organic acid: 2,5-dihydroxybenzoic acid (2,5-dihydroxybenzoic acid, DHB) was dissolved in 3 ml of secondary deionized water, and 0.01 N HCl was added to obtain a mixture F.
(9)將混合物E與混合物F於室溫下反應12小時,以得到混合物G。將混合物G依序以丙醇和二次去離子水進行清洗,並用高速離心去除上清液,以得到混合物H。再加入0.1N NaOH於混合物H中,依序以丙醇和二次去離子水進行清洗,最後以高真空進行乾燥,以得到金屬奈米粒子。 (9) The mixture E and the mixture F were reacted at room temperature for 12 hours to obtain a mixture G. The mixture G was washed sequentially with propanol and secondary deionized water, and the supernatant was removed by high speed centrifugation to obtain a mixture H. Further, 0.1 N NaOH was added to the mixture H, followed by washing with propanol and secondary deionized water, and finally dried under high vacuum to obtain metal nanoparticles.
取實施例1之金屬奈米粒子,以溶劑回溶金屬奈米粒子,製作成1000ppm的奈米粒子溶液,溶劑例如二次去離子水、甲醇、乙晴(acetonitrile,ACN)或1,4-二氧雜環己烷(1,4-dioxane)。 Taking the metal nanoparticles of Example 1 and solvent-resolving the metal nanoparticles to prepare a 1000 ppm solution of nano particles, such as secondary deionized water, methanol, acetonitrile (ACN) or 1,4-. Dioxane (1,4-dioxane).
將表1的各種不同樣品點附於TLC板上,藉由薄層層析法(thin layer chromatography)分離該些化合物並得到複數個分析點,分離溶液顯示於表1中。 The various sample points of Table 1 were attached to TLC plates, and the compounds were separated by thin layer chromatography and a plurality of analytical points were obtained. The separated solutions are shown in Table 1.
之後,將1000ppm的奈米粒子溶液滴於該些分析點,使該些化合物吸附於奈米粒子溶液中。之後,對TLC板進行一乾燥步驟。 Thereafter, a 1000 ppm solution of nanoparticle was dropped on the analysis points to adsorb the compounds in the nanoparticle solution. Thereafter, a drying step is performed on the TLC plate.
接著,以導電膠脫附於TLC板背面,並黏著於不鏽鋼(stainless)樣品盤上,將TLC板直接置入一質譜儀中,以進行質譜分析。第2A-2H圖分別顯示樣品標號1-8的質譜圖。 Next, the conductive paste was desorbed on the back side of the TLC plate and adhered to a stainless steel sample tray, and the TLC plate was directly placed in a mass spectrometer for mass spectrometry analysis. Figures 2A-2H show mass spectra of sample numbers 1-8, respectively.
由第2G圖可知,本發明之分析方法用於偵測膽固醇時,其靈敏度為100fg,0.26fmol(S/N ratio=4)。 As can be seen from Fig. 2G, the sensitivity of the analytical method of the present invention for detecting cholesterol is 100 fg and 0.26 fmol (S/N ratio = 4).
由第2H圖可知,本發明之分析方法用於偵測磺胺類時,其靈敏度為1ng,2pmol(S/N ratio=3)。 As can be seen from Fig. 2H, the sensitivity of the analytical method of the present invention for detecting sulfonamides is 1 ng, 2 pmol (S/N ratio = 3).
實施例3之金屬奈米粒子類似於實施例1,差別僅在於有機 酸改為α-氰基-4-羟基肉桂酸(α-Cyano-4-hydroxycinnamic acid,α-CHC)。 Metal nanoparticles of Example 3 was similar to Example 1, the only difference that the organic acid to α- cyano-4-hydroxycinnamic acid (α-Cyano-4-hydroxycinnamic acid, α -CHC).
將實施例3之奈米溶液以溶劑回溶,製作1000ppm的奈米粒子溶液。 The nano-solution of Example 3 was re-dissolved in a solvent to prepare a 1000 ppm solution of nanoparticle.
之後,將樣品點附於TLC板上,藉由薄層層析法(thin layer chromatography)分離該些化合物並得到單一個分析點。 Thereafter, the sample spots were attached to a TLC plate, and the compounds were separated by thin layer chromatography and a single analysis point was obtained.
之後,將1000ppm的奈米粒子溶液滴於該些分析點,使該些化合物吸附於奈米粒子溶液中。之後,對TLC板進行一乾燥步驟。 Thereafter, a 1000 ppm solution of nanoparticle was dropped on the analysis points to adsorb the compounds in the nanoparticle solution. Thereafter, a drying step is performed on the TLC plate.
接著,以導電膠黏貼於TLC板背面,並黏著於不鏽鋼(stainless)樣品盤上,將TLC板直接置入一質譜儀中,以進行質譜分析。 Next, a conductive adhesive was adhered to the back surface of the TLC plate, and adhered to a stainless steel sample tray, and the TLC plate was directly placed in a mass spectrometer for mass spectrometry.
第3圖顯示偵測到山梨醣醇(sorbitol)的質譜圖。 Figure 3 shows the mass spectrum of sorbitol detected.
請參見反應機制1,起始物為甲氧基三乙二醇(methoxyl triethylene glycol,C7H16O4,分子量164.1)與2-氯-2-苯基乙烯氯(2-chloro-2-phenylacetyl chloride)反應後,會得到酯類產物(C15H21ClO5,分子量316.1)。 See Reaction Scheme 1. The starting material is methoxyl triethylene glycol (C 7 H 16 O 4 , molecular weight 164.1) and 2-chloro-2-phenylvinyl chloride (2-chloro-2- After the phenylacetyl chloride reaction, an ester product (C 15 H 21 ClO 5 , molecular weight 316.1) is obtained.
請參見表2,其顯示起始物(compound I)與產物(compound II)使用不同分析方法所偵測到的質譜分析結構。 See Table 2, which shows the mass spectrometric structures detected by different analytical methods for the compound I and the compound II.
請參見第4A圖與第4D圖,其分別顯示起始物與產物經由薄層層析法(TLC)分離之後,於不添加任何基質的條件下,由質譜分析(MALDI MS)所得到之訊號圖。由第4A圖與第4D圖中得知,由於並未使用任何基質,所以無法偵測到任何訊號。 Please refer to FIG. 4A and FIG. 4D, which respectively show the signals obtained by mass spectrometry (MALDI MS) after separation of the starting materials and products by thin layer chromatography (TLC) without adding any matrix. Figure. It is known from Figures 4A and 4D that no signal can be detected since no substrate is used.
請參見第4B圖與第4E圖,其分別顯示起始物與產物經由薄層層析法分離之後,於添加DHB作為基質的條件下,由質譜分析所得到之訊號圖。由第4B圖與第4E圖中得知,使用DHB作為基質,由於DHB的碎片(fragments)會產生很多訊號,因此,背景訊號會干擾所欲分析的化合物的訊號。 Please refer to FIG. 4B and FIG. 4E, which respectively show signal diagrams obtained by mass spectrometry after separation of the starting materials and products by thin layer chromatography under the condition of adding DHB as a matrix. It is known from Figures 4B and 4E that using DHB as a substrate, since the fragments of DHB generate a lot of signals, the background signal interferes with the signal of the compound to be analyzed.
請參見第4C圖與第4F圖,其分別顯示起始物與產物經由薄層層析法分離之後,將奈米粒子溶液(DHB@MNPs)滴於起始物與產物之上,由質譜分析所得到之訊號圖。由第4C圖中可觀察到起始物結合鈉的訊號(m/z=187.1),由第4F圖中可觀察到產物結合鈉的訊號(m/z=339.1)。 Please refer to FIG. 4C and FIG. 4F, respectively, showing that the starting material and the product are separated by thin layer chromatography, and the nanoparticle solution (DHB@MNPs) is dropped on the starting material and the product, and analyzed by mass spectrometry. The resulting signal map. From page 4C, a signal for the binding of sodium to the starting material (m/z = 187.1) was observed, and a signal for the product to bind sodium (m/z = 339.1) was observed from Figure 4F.
請參見表3,其顯示化合物I與化合物II之偵測靈敏度。 See Table 3 for the detection sensitivity of Compound I and Compound II.
反應機制2顯示由4-二甲氨基吡啶(4-dimethylaminopyridine,DMAP)所催化的醯化反應(acylation),可藉由本發明之分析方法監控反應過程中的中間產物(intermediate III),以及監控產物(product IV)。 Reaction Scheme 2 shows the acylation catalyzed by 4-dimethylaminopyridine (DMAP), which can be monitored by the analytical method of the present invention, and the intermediate product is monitored and the product monitored. (product IV).
第5A圖顯示中間產物(intermediate III)之質譜圖,第5B圖顯示產物(product IV)之質譜圖。由此可知,本發明所揭露之化合物之分析方法可應用於及時(real time)監控化學反應,以判斷反應完成與否。 Figure 5A shows the mass spectrum of the intermediate product (intermediate III), and Figure 5B shows the mass spectrum of the product (product IV). It can be seen that the analytical method of the compound disclosed in the present invention can be applied to monitor the chemical reaction in real time to judge whether the reaction is completed or not.
取天然物錫蘭七指蕨(Helminthostachys zeylanica)的根莖(rhizomes)進行分析,可得到一系列的抗發炎的類黃酮素家族(anti-inflammatory flavonoid family),包括黃酮類化合物(ugonins J-X)。 A series of anti-inflammatory flavonoid families, including flavonoids (ugonins J-X), were obtained from the rhizomes of the natural product, Helminthostachys zeylanica.
第6A圖顯示ugonins J之質譜圖。第6B圖顯示ugonins L之質譜圖。 Figure 6A shows the mass spectrum of ugonins J. Figure 6B shows the mass spectrum of ugonins L.
雖然本發明已以數個較佳實施例揭露如上,然其並非用以限定本發明,任何所屬技術領域中具有通常知識者,在不脫離本發明之精神和範圍內,當可作任意之更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 While the invention has been described above in terms of several preferred embodiments, it is not intended to limit the scope of the present invention, and any one of ordinary skill in the art can make any changes without departing from the spirit and scope of the invention. And the scope of the present invention is defined by the scope of the appended claims.
12‧‧‧基板 12‧‧‧Substrate
14‧‧‧滴管 14‧‧‧ Dropper
16‧‧‧奈米粒子溶液 16‧‧‧Nano particle solution
S1、S2、S3‧‧‧分析點 S1, S2, S3‧‧‧ analysis points
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW102116006A TWI512291B (en) | 2013-05-06 | 2013-05-06 | Method for detecting compound by thin-layer chromatograph mass spectrometry |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW102116006A TWI512291B (en) | 2013-05-06 | 2013-05-06 | Method for detecting compound by thin-layer chromatograph mass spectrometry |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201443432A TW201443432A (en) | 2014-11-16 |
TWI512291B true TWI512291B (en) | 2015-12-11 |
Family
ID=52423310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW102116006A TWI512291B (en) | 2013-05-06 | 2013-05-06 | Method for detecting compound by thin-layer chromatograph mass spectrometry |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI512291B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106932524B (en) * | 2015-12-30 | 2018-11-27 | 中国科学院化学研究所 | Thin layer of liquid chromatograph-mass spectrometer coupling device, purposes and detection method |
CN111060645A (en) * | 2019-12-25 | 2020-04-24 | 安徽中科赛飞尔科技有限公司 | SERS detection method for adulterated drugs |
CN111189954A (en) * | 2019-12-28 | 2020-05-22 | 安徽中科赛飞尔科技有限公司 | Method for detecting drugs in hair by TLC-SERS |
-
2013
- 2013-05-06 TW TW102116006A patent/TWI512291B/en not_active IP Right Cessation
Non-Patent Citations (1)
Title |
---|
Beate Fuchs et al, Chromatography Supplement Vol.69,S95-S105,2009. Mei-Chun Tseng et al, J Am Soc Mass Spectrom ,Vol.21,p.1930-1939,2010/08/05. Ryuichi Arakawa & Hideya Kawasaki, Analytical Science,Vol.26,p.1229-1240,2010/12/10. * |
Also Published As
Publication number | Publication date |
---|---|
TW201443432A (en) | 2014-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rodgers et al. | Combating selective ionization in the high resolution mass spectral characterization of complex mixtures | |
US8617898B2 (en) | Quantitative analysis of vitamin D3, vitamin D2, and metabolites thereof | |
JP5054694B2 (en) | Mass label | |
JP5396277B2 (en) | Automatic sugar chain pretreatment equipment | |
EP4226946B1 (en) | Method for reducing matrix effects in analytical sample | |
JP2007510141A (en) | Reactive polyurethane-based polymer | |
CA2488623A1 (en) | System and method for the preparation of arrays of biological or other molecules | |
TWI512291B (en) | Method for detecting compound by thin-layer chromatograph mass spectrometry | |
CN103063730B (en) | Application of naphthylhydrazine inorganic acid salt or Naphthylhydrazine organic acid salt as matrix in MALDI MS (matrix-assisted laser desorption/ionization mass spectrometry) | |
CN110044998B (en) | Quantification of tamoxifen and its metabolites by mass spectrometry | |
Nielsen et al. | Rapid screening of drug compounds in urine using a combination of microextraction by packed sorbent and rotating micropillar array electrospray ionization mass spectrometry | |
CN102603707A (en) | 2,3,4,5,-tetra(3',4'-dihydroxyl phenyl)thiophene and application thereof as MALDI (matrix assisted laser desorption ionization) matrix in analyzing small molecules | |
Szabo et al. | Laser desorption/ionization mass spectrometric analysis of small molecules using fullerene‐derivatized silica as energy‐absorbing material | |
WO2004092707A3 (en) | Aromatic phosphonium salts and their use as labeling reagents mass spectrometry analysis | |
JP2023546477A (en) | Detection of analytes of interest by nanoESI mass spectrometry | |
JP2023525913A (en) | Benzylpyridinium Reagents for Mass Spectrometry | |
Zhu et al. | Phenol-selective mass spectrometric analysis of jet fuel | |
WO2009131403A1 (en) | Mass spectrometric method for matrix-free laser desorption/ionization of self-assembled monolayers | |
CN115667223A (en) | Imidazolium reagents for mass spectrometry | |
CN115667933A (en) | Reagent for mass spectrometry | |
CN115667934A (en) | Reagent for mass spectrometry | |
KR20210035812A (en) | Reagents for mass spectrometry | |
US20230273217A1 (en) | Derivatization of at least one analyte of interest for mass spec measurements in patient samples | |
CN103604861A (en) | Application of anthraquinone or anthraquinone derivatives as matrix in matrix assisted ultraviolet-visible light laser desorption / ionization mass spectrometry | |
JP7576708B2 (en) | Glycan Analysis Method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |